For Diagnostic Products Sample Clauses
For Diagnostic Products. In consideration of the rights and licenses granted to Merck regarding Diagnostic Products in this Agreement, Merck shall pay to Acumen the following royalties:
(1) For those Diagnostic Products sold by Merck or its Affiliates to a Third Party, the royalty rate shall be as follows: [***] [***] [***] [***] [***] [***]
(2) For those Diagnostic Products for which Merck or its Affiliates receive Diagnostic Received Revenue from a Third Party, the royalty rate shall be as follows: [***] [***] [***] [***] [***] [***]
For Diagnostic Products. (i) For a given Selected Disease, commencing nine (9) months after the Effective Date, at any time during the term of this Agreement prior to the first Registration in any Major Country of a Diagnostic Product for such Selected Disease, Roche may, for any reason, terminate this Agreement with respect to all Diagnostic Products for the Selected Disease by giving six (6) months' prior written notice to deCODE. In such event, the effective date of termination shall be the date six (6) months after Roche provides such written notice to deCODE. The effects of such termination shall be governed by Section 14.4(b)(ii). After the effective date of such termination, in no event shall Roche, its Affiliates or sublicensees make, have made, use, offer for sale, sell or import Diagnostic Products for such Selected Disease.
(ii) For a given Selected Disease, commencing nine (9) months after the Effective Date, at any time during the term of this Agreement after the first Registration in any Major Country of a Diagnostic Product for such Selected Disease, Roche may, for any reason, terminate this Agreement in a given Major Country with respect to all Diagnostic Products for the Selected Disease by giving six (6) months' prior written notice to deCODE. In such event, the effective date of termination shall be the date six (6) months after Roche provides such written notice to deCODE. The effects of such termination shall be governed by Section 14.4(b)(iii). After the effective date of such termination, in no event shall Roche, its Affiliates or sublicensees make, have made, use, offer for sale, sell or import Diagnostic Products for such Selected Disease in such given Major Country.